AVEO ONCOLOGY
AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough, and Biogen Idec. The company was established in 2001 and is based in Cambridge, Massachusetts.
AVEO ONCOLOGY
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aveooncology.com
Total Employee:
101+
Status:
Active
Contact:
857-400-0101
Total Funding:
560.85 M USD
Technology used in webpage:
Domain Not Resolving HSTS Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style COVID-19 Smart App Banner Apple Mobile Web Clips Startup Comcast WPTouch Pro
Similar Organizations
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
ANI Pharmaceuticals
ANI Pharmaceuticals manufactures oral solid dose products, as well as liquids and topicals.
BioVectra
BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.
CASI Pharmaceuticals
CASI focus on building a pipeline through mutually beneficial business development transactions.
Ligand Pharmaceuticals
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - AVEO Oncology
New Leaf Venture Partners
New Leaf Venture Partners investment in Post-IPO Equity - AVEO Oncology
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - AVEO Oncology
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - AVEO Oncology
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - AVEO Oncology
Hercules Capital
Hercules Capital investment in Post-IPO Equity - AVEO Oncology
OSI Pharmaceuticals
OSI Pharmaceuticals investment in Venture Round - AVEO Oncology
Venrock
Venrock investment in Series D - AVEO Oncology
Prospect Venture Partners
Prospect Venture Partners investment in Series C - AVEO Oncology
MPM Bio IV NVS Strategic Fund
MPM Bio IV NVS Strategic Fund investment in Series C - AVEO Oncology
Key Employee Changes
Official Site Inspections
http://www.aveooncology.com Semrush global rank: 4.84 M Semrush visits lastest month: 1.8 K
- Host name: ec2-3-139-141-81.us-east-2.compute.amazonaws.com
- IP address: 3.139.141.81
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "AVEO Oncology"
Corporate Overview - Aveo Oncology
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients.See details»
Management Team - Aveo Oncology
The AVEO Oncology, an LG Chem company, management team comprises executives with years of oncology and pharmaceutical industry experience and expertise, and a proven track record …See details»
AVEO Oncology - Crunchbase Company Profile
AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics.See details»
AVEO Oncology - LinkedIn
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.See details»
AVEO Oncology Company Overview, Contact Details
Mar 22, 2021 [email protected]: [email protected]: 5%. [email protected]: [email protected]: 1%. See more formats. Frequently Asked …See details»
AVEO Oncology, and LG Chem Company - BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash
Oct 18, 2022 The combination of LG Chem’s Life Sciences division and AVEO is expected to create a global oncology organization with a robust portfolio of innovative products supported …See details»
AVEO Pharmaceuticals - Overview, News & Similar companies
Jun 13, 2024 AVEO Pharmaceuticals contact info: Phone number: (857) 400-0101 Website: www.aveooncology.com What does AVEO Pharmaceuticals do? AVEO Pharmaceuticals, Inc., …See details»
About - Aveo Oncology
© 2012 AVEO Pharmaceuticals, Inc. All rights reserved. Terms of Use Privacy Policy Cookie Notice Code of Business Conduct and Ethics. Cookie SettingsSee details»
LG Chem company and AVEO Oncology Announce LG Chem's …
Jun 13, 2024 LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109 …See details»
AVEO Oncology Information - RocketReach
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.See details»
AVEO Oncology Announces Participation at the 11th Annual SVB …
A live webcast of the fireside chat can be accessed by visiting the investors section of the Company’s website at www.aveooncology.com. A replay of the. BOSTON, Feb. 03, 2022 …See details»
Overview - Aveo Oncology
“AVEO Oncology is a patient focused, science driven company which fosters a collaborative work environment in the pursuit of our mission to provide the oncology community with improved …See details»
LG Chem to Acquire AVEO Oncology for $15.00 Per Share in
Oct 18, 2022 The combination of LG Chem’s Life Sciences division and AVEO is expected to create a global oncology organization with a robust portfolio of innovative products supported …See details»
AVEO Pharmaceuticals - Company Profile & Staff Directory
AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets …See details»
AVEO Oncology - PitchBook
AVEO Oncology General Information Description. AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that …See details»
AVEO Oncology Announces New Corporate Headquarters in …
May 26, 2015 “AVEO is now a streamlined organization with its resources squarely focused on the execution of a strategy aimed at leveraging biomarker insights and exploring partnership …See details»
AVEO Oncology Reports Third Quarter 2022 Financial Results
Nov 7, 2022 The combination of LG Chem’s Life Sciences division and AVEO is expected to create a global oncology organization with a robust portfolio of innovative products supported …See details»
AVEO Oncology Announces U.S. FDA Approval of FOTIVDA
Mar 10, 2021 Please see FOTIVDA Full Prescribing Information which is available at www.AVEOoncology.com. About Advanced Renal Cell Carcinoma. According to the American …See details»